Home › Funds › PSP Research LLC › SUPN

PSP Research LLC position in SUPN

SUPERNUS PHARMACEUTICALS · Health Care

PSP Research LLC reported holding 6,000 shares of SUPN (SUPERNUS PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$258K, representing 0.18% of its reported portfolio and ranking #15 among its reported holdings. PSP Research LLC has disclosed SUPN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)6.00K sh
Reported value held$258.24K
Portfolio Weight0.18%
First reportedQ4 2025
Last changeHold
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's SUPN position evolved

PSP Research LLC first disclosed a stake in SUPN in Q4 2025 at 10,758 shares (US$535K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 6,000 shares valued at US$258K. Notable position changes include a 44% trim in Q1 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 10.76K $534.67K New
Q1 2026 6.00K $310.14K Reduce
Q2 2026 6.00K $279.06K Hold
Q3 2026 6.00K $258.24K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SUPN and 13F data

SUPN (SUPERNUS PHARMACEUTICALS) is a Health Care company. 35 other funds we track also report a position in SUPN — the largest reported positions include MILLENNIUM MANAGEMENT LLC (US$179.2M), ARMISTICE CAPITAL, LLC (US$123.1M), Sofinnova Investments, Inc. (US$48.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SUPN

All SUPN fund holders →

FAQ

How long has PSP Research LLC held SUPN?

PSP Research LLC has disclosed SUPN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in SUPN?

As of Q3 2026, PSP Research LLC holds 6.00K shares of SUPN (SUPERNUS PHARMACEUTICALS), valued at $258.24K, representing 0.18% of its reported portfolio and ranking #15.

Has PSP Research LLC been buying or selling SUPN?

In the latest 13F filing (Q3 2026), PSP Research LLC held unchanged its position in SUPN.

Which other funds hold SUPN?

Other major institutional holders of SUPN include MILLENNIUM MANAGEMENT LLC, ARMISTICE CAPITAL, LLC, Sofinnova Investments, Inc., among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.